{"name":"Oscotec Inc.","slug":"oscotec-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":".[14C]-SKI-O-703","genericName":".[14C]-SKI-O-703","slug":"14c-ski-o-703","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":".[14C]-SKI-O-703","genericName":".[14C]-SKI-O-703","slug":"14c-ski-o-703","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-30","type":"earnings","source":"simplywall.st","summary":"Oscotec's (KOSDAQ:039200) Earnings Are Weaker Than They Seem - simplywall.st","headline":"Oscotec's (KOSDAQ:039200) Earnings Are Weaker Than They Seem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOMWJ0cXY0WmVJQXlEVTRxcXE5SDlTanJiTmpBcEtveEJPZXJXbnpvQnNDY2JSQXlRLVRKTlRPaUxCaWlrRUNNQ24yZHhoS3lVenpSM0hFaXdOZzZ2ejduUV9CbHNqUjJHZEZ6bVVfQnJsSW0wSXZrVExJNEFFZWVnazJKQVFtQ2lz?oc=5","date":"2026-01-11","type":"pipeline","source":"조선일보","summary":"Global Pharma, South Korean Firms Intensify Dementia Drug Race - 조선일보","headline":"Global Pharma, South Korean Firms Intensify Dementia Drug Race - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5vbjUxRnpQUVNSOHJuQ0FJdk5MWGp5RTNzX3l1ZXdraXA3Q3hxSC1BZkxYak9MSVV4QmIyQWRNNVVWczJiazNuOHdwSy1XQ181bkZIbmo0a1V5eHhvS09kaVNDTU96U0VDYnVTdjl30gFyQVVfeXFMTVZOQ0l1cGZiQURTR0s2MGV0eUdYcHd3TlpZTll3bXloV18tMF9BSXZfNDIwdDFIeUZkak96c19QZ2w5SlY2bUVlMjAtM004bzRaeXF6MkJPZGxOdTJ3OHRtMGdYSncyWVh4cDBJSjgwMEFR?oc=5","date":"2025-12-26","type":"pipeline","source":"koreabiomed.com","summary":"‘Oscotec proves competitiveness in targeting tau protein for Alzheimer’s treatment with tech transfer to Sanofi’ - koreabiomed.com","headline":"‘Oscotec proves competitiveness in targeting tau protein for Alzheimer’s treatment with tech transfer to Sanofi’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTE5SNlB4SGVKaWhhQkNsaVpkOFVpR0tnVjVQUENxZlR3Sm5KMTVaTFdLaGlrY2V0NUhicWJpTHNreEpHUQ?oc=5","date":"2025-12-16","type":"deal","source":"코메디닷컴","summary":"Oscotec and ADEL License Alzheimer’s Drug Candidate to Sanofi in KRW 1.5 Trillion Deal - 코메디닷컴","headline":"Oscotec and ADEL License Alzheimer’s Drug Candidate to Sanofi in KRW 1.5 Trillion Deal - 코메디닷컴","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPYXpPYnZsWFo3Q0xZT2VrZ01uUW5EMlhUdDFKSWdKYkZGeGlNSnd5ZEgxOUpVeU00cEdkanViWElaZkVwVVdFc1AyZnRPd1FSdWcxaWY0OW1UWXk4bWdaZGlOMXhwLTg3UVdyRFlpWmZNeDFPei1XTlhjQUVEd1FNetIBlAFBVV95cUxOTzI5anhvQWVyNDFMd1ZPaXViTFlndkZ2bnFLVTh6b0xkSWlvbDRSaVhGT0E5YXUyUm93VmJ5aUZoay1iYkNLcTNRdHN6MVRUeWppeVhNaldCaF82OEhKbEpwVi14RmhkenZkLVJhZ3E2cTZ6U3RRc1VNeHRxWC1sdVJ5a29IRF9OVWdoRGh1NUt6Vktf?oc=5","date":"2025-11-18","type":"regulatory","source":"Chosunbiz","summary":"Oscotec starts spin-off to buy remaining Genosco shares and secure control - CHOSUNBIZ - Chosunbiz","headline":"Oscotec starts spin-off to buy remaining Genosco shares and secure control - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPdGJaTjFtZURoZUtuV0JvZXpZcGo1LXRhRHRwZUIxWDhmWTRnZzM5ci12b2N0TVlLWUtvWlJvNVdHa3Q0NDRiZVFaVlFBUDVIYXdhRTFhaTF2dDBZR2MtaDZRU29UTDliNGNoOXBUSkJsa2F1T0tfYjgwTTZRc2paVNIBlAFBVV95cUxQdHZvWVFTOVNGbTFWNDluMDFrU0YtQWduYUx3U0lJaTNKaWRlMDA1QlRRTTRpWTZKQ3p1VndsY2M2MFBUcGNGZmQ5SzhjYU9EYmRqWUp6Yk9taHV3ajVDYVIzSEFqUHMxT3Faak8tLTh1cFdSTHhYQ1JHOWNEeXNOMlkxcHNXaXVfaUJ0ems4YmdJcE1q?oc=5","date":"2025-07-02","type":"pipeline","source":"Chosunbiz","summary":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ - Chosunbiz","headline":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBPZXVXdnpzd1hidElkNC1acHZQSGhuR1NjS1NGM2psVWdCN0NjUXM2Rm1jeGxJVW9iX19TMnhCWEE3MkttQVNlSUpLNzZ4QVdydW1ZTjhSQlpud3RsYnhqYnlUUE1GTmJLWTQ1QlZR0gFyQVVfeXFMUDlCSTZ3eEZXQkZKS2JFTHNFbnlZeWdkTWJiN2tPYVdlOHBRT3Q2NkRLaDhIMW9ScHhaTk9iMDE3NF9SQ25aVmdhT1NYeHdHcGNmLVlhQjh1ZTJRZGpud2otQ1ZfSThrcHZXbzZCVFlOWGdB?oc=5","date":"2025-03-13","type":"pipeline","source":"koreabiomed.com","summary":"Oscotec faces investor backlash over Genesco IPO as CEO warns of R&D shutdown - koreabiomed.com","headline":"Oscotec faces investor backlash over Genesco IPO as CEO warns of R&D shutdown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQSDRlcTFteFU3MEkzSnNQdTRXV2RZMTZ4RGk1ZTkyblltZTI1SDBBWjkzUnhNVmpTRkM1dDk0YnA3VWlJcVZnQ0pMMllPQ3RkOENmYkRxYldTcVpLQkh6ZEYxWUVUSlNXWVZsS3ZnazZRR3BzSllPNUFvM1hTRXdudjZacm91QkFGWkluWlZOdThaLUpXU2QwVS1JV0dzdFZndVJHVHdEMVJ6UkpxVUUwUFdXRENxLUtOTjdSMGdqWHdrNUkwVTBPdjlQazB5Z3hjTktIbXROcmt0Uk5XNThfVnRYVF9KQlY2bVhCUW5sRGdXUVdiTE9pdGFVRy0xVVliNjNMZFRfblpfVkdsSENjQ2RLdThzczQ?oc=5","date":"2025-03-04","type":"regulatory","source":"PR Newswire UK","summary":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight - PR Newswire UK","headline":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1jTHhGaFlvSWtFNnh2ODI4R1BMcllrb19fNWlINWZGS2ZrT2JUNEpEMThZTjRUbUZfQ2NCYkc2UlhTMFdLaFZNWFpRUTBuWlRVOHJQNWhyMTVNRjY3UXp2ejdqM0Y0UmM1MHdZQlF3?oc=5","date":"2024-08-21","type":"regulatory","source":"KED Global","summary":"Yuhan’s lung cancer drug clears FDA hurdle for global debut - KED Global","headline":"Yuhan’s lung cancer drug clears FDA hurdle for global debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOLUpoQmlMeVJzR0h3Rm84LXRzTXpCQUlBWUtRb1oyMWQwOTUzQUNSaFNvZDRDLUVJY1VUOVZiU3FiZHd5S3E0c1d0ZDVpbEJvNllRLXA0SDZtOGdDMXVBamtQcUdQUTJveENvRDI3MldRY1g2OWxRT05fYUMxVEdCY0VDam51ZDRwMm9LdGRUNndiQk9KNUM2ZFBuR1VxRl8wTk1Dc3o0Q2E4b0JMM2hn?oc=5","date":"2024-03-25","type":"regulatory","source":"pharmacytimes.com","summary":"FDA Grants ODD to Cevidoplenib for the Treatment of Immune Thrombocytopenia - pharmacytimes.com","headline":"FDA Grants ODD to Cevidoplenib for the Treatment of Immune Thrombocytopenia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxORlBmWmZwbkNBR0FWck8zbzBPeGR1ZE1naWdONmZfOTV5emJ2RlVkdzJtbUZaOXhaLUlVem1lZWxJeFFnUGJVYUQ1cUZLRTVvV1cxYlFReldLZ1NSaFdOSVZNOWhTdm9pdFo4Q1hiV2FUX3A2RzBTMGlqV1g2NkZ5UjhvRlQxOHE4WERVMWtGa1ZFdjZfd2tPMUhwSHEta1hudVctX3JwSFNHRmdZWUxwWmN1bzhtVjNnbEptUnFB?oc=5","date":"2024-02-26","type":"trial","source":"BioPharma APAC","summary":"Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01 - BioPharma APAC","headline":"Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYXFwZ3BwV3JmVkVSakFUUnpaQVhFcFdseXlEY3RIUUdTMFVlaC1HR0RuQkhYSDYzQW1UcGU3R2pHOGZOUHhKUjdtQ3FPQzcwY1VVLWJPOUFjZUdkS3FVSExlRUJmdlNaZHJTNDB1bktlMHVwQ04xdnoxQTI5WWg2MnJ1UmZ5NGUxMnVqbS13dzdKdUZ5RlZNS2xoWVVRWmpPRTBpbUZLMF9SVVFXYWRJeXlZYkRqd2NBXzV0OE9wU1p4YXM1enVtbl9zRElqQjhpX0swUldGcy0xTlRXbU5lbG9HeXhreEg3elllYW1Hc2RSY3pTU3ZWWEVIYWE1NV90Uld3X05vbXQ?oc=5","date":"2022-07-26","type":"pipeline","source":"PR Newswire","summary":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight - PR Newswire","headline":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsi","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}